The THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 06mg/kg trial aims to determine the efficacy and safety of intravenous thrombolysis with alteplase at 06mg/kg body weight , the approved dose for Japanese stroke patients , using magnetic resonance image-based selection in ischemic stroke patients with unclear time of symptom onset , and compare findings with standard treatment .